1. P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study. (December 2020) Authors: William, Sandborn; Geert, D'Haens; Doug, Wolf; Stephen, Hanauer; Igor, Jovanovic; Subrata, Ghosh; AnnKatrin, Petersen; Steven, Hua; Hwan, Lee Ji; Lorna, Charles; Keith, Usiskin; Silvio, Danese; Brian, Feagan Journal: American journal of gastroenterology Issue: Volume 115:Supplement(2020)Advances in Inflammatory Bowel Diseases Annual Meeting Abstracts1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P030 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Maintenance in the Phase 3 True North Study. (December 2020) Authors: Silvio, Danese; Brian, Feagan; Stephen, Hanauer; Igor, Jovanovic; Subrata, Ghosh; AnnKatrin, Petersen; Steven, Hua; Hwan, Lee Ji; Lorna, Charles; Denesh, Chitkara; William, Sandborn; Geert, D'Haens Journal: American journal of gastroenterology Issue: Volume 115:Supplement(2020)Advances in Inflammatory Bowel Diseases Annual Meeting Abstracts1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 Trial. (December 2021) Authors: Jean-Frederic, Colombel; Geert, D'Haens; Peter, Irving; AnnKatrin, Petersen; Denesh, Chitkara; Cecilia, Marta; Tianlei, Chen; Lorna, Charles; Silvio, Danese; Subrata, Ghosh Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)Advances in Inflammatory Bowel Diseases Annual Meeting Abstracts 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗